Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

»õ·Î °³¹ßµÇ°í ÀÖ´Â BÇü°£¿° Ä¡·á¹ý New Potential Therapies for Chronic Hepatitis B

´ëÇѼÒÈ­±âÇÐȸÁö 2019³â 74±Ç 5È£ p.267 ~ 273
À¯¼±È«, ±ÇÁ¤Çö,
¼Ò¼Ó »ó¼¼Á¤º¸
À¯¼±È« ( Yoo Sun-Hong ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÎõ¼º¸ðº´¿ø ¼ÒÈ­±â³»°ú

±ÇÁ¤Çö ( Kwon Jung-Hyun ) 
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ÀÎõ¼º¸ðº´¿ø ¼ÒÈ­±â³»°ú

Abstract


A HBV infection is a dynamic disease and long-term liver inflammation contributes to the development of liver cirrhosis and hepatocellular carcinoma. Currently available nucleos(t)ide analogues and pegylated interferon are effective in inhibiting HBV replication but rarely achieve HBsAg clearance. The present article introduces a new definition of HBV cure and several emerging therapies for HBV cure, including direct acting antivirals and immune modulatory antivirals.

Å°¿öµå

Hepatitis B virus; Therapeutics

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS